Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, S. | - |
dc.contributor.author | Han, B. | - |
dc.contributor.author | Kim, S. | - |
dc.contributor.author | Han, S. | - |
dc.contributor.author | Jo, Y. -I. | - |
dc.contributor.author | Jeong, K. | - |
dc.contributor.author | Oh, K. -H. | - |
dc.contributor.author | Park, H. | - |
dc.contributor.author | Park, S. -H. | - |
dc.contributor.author | Kang, S. -W. | - |
dc.contributor.author | Na, K. -R. | - |
dc.contributor.author | Jang, Y. | - |
dc.contributor.author | Kim, S. -H. | - |
dc.contributor.author | Cha, D. | - |
dc.date.available | 2021-01-13T07:42:54Z | - |
dc.date.issued | 201509 | - |
dc.identifier.issn | 0012-186X | - |
dc.identifier.issn | 1432-0428 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/47371 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment | - |
dc.type | Conference | - |
dc.identifier.doi | 10.1007/s00125-015-3687-4 | - |
dc.citation.title | DIABETOLOGIA | - |
dc.citation.startPage | S804 | - |
dc.citation.endPage | S804 | - |
dc.citation.conferenceName | 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) | - |
dc.citation.conferencePlace | 미국 | - |
dc.citation.conferencePlace | Stockholm, SWEDEN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.